Cargando…
Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches
Drug hypersensitivity reactions (HSRs) are increasing in the 21st Century with the ever expanding availability of new therapeutic agents. Patients with cancer, chronic inflammatory diseases, cystic fibrosis, or diabetes can become allergic to their first line therapy after repeated exposures or thro...
Autores principales: | de las Vecillas Sánchez, Leticia, Alenazy, Leila A., Garcia-Neuer, Marlene, Castells, Mariana C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486137/ https://www.ncbi.nlm.nih.gov/pubmed/28632196 http://dx.doi.org/10.3390/ijms18061316 |
Ejemplares similares
-
Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers
por: Jimenez-Rodriguez, Teodorikez Wilfox, et al.
Publicado: (2018) -
Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations
por: Castells, Mariana
Publicado: (2017) -
Differential outcomes of 609 rapid drug desensitization (RDD) for type I hypersensitivity to platins and taxanes
por: Caiado, Joana, et al.
Publicado: (2014) -
Desensitization for the prevention of drug hypersensitivity reactions
por: Kang, Sung-Yoon, et al.
Publicado: (2022) -
Utilizing Biologics in Drug Desensitization
por: Yang, Barbara C., et al.
Publicado: (2022)